Abstract
Serum estriol levels have been investigated in patients receiving short-term (2 h) intravenous prophylactic (8 women) or therapeutic (8 women) Β-receptor agonist treatment. None of the patient groups responded with a change in unconjugated estriol or in total serum estriol. This was the case whether isoxsuprine or terbutaline was used. The importance of future studies on estriol metabolism during long-term Β-receptor agonist therapy is emphasized.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
